ESSA Pharma Inc. EPIX
Trading inactive
| Déclarant | Citoyenneté ou lieu d'organisation | Pouvoir de vote unique | Pouvoir de vote partagé | Pouvoir de disposition unique | Pouvoir de disposition partagé | Montant en propriété effective | Pourcentage détenu | Date d'achat |
|---|---|---|---|---|---|---|---|---|
| TANG CAPITAL PARTNERS, LP | DELAWARE | 0 | 4300000 | 0 | 4300000 | 4300000 | 9.7 % | 08/11/2024 |
| TANG CAPITAL MANAGEMENT, LLC | DELAWARE | 0 | 4300000 | 0 | 4300000 | 4300000 | 9.7 % | 08/11/2024 |
| KEVIN TANG | UNITED STATES | 0 | 4300000 | 0 | 4300000 | 4300000 | 9.7 % | 08/11/2024 |
| Concentra Biosciences, LLC | DELAWARE | 0 | 0 | 0 | 0 | 0 | 0 % | 08/11/2024 |
| TANG CAPITAL PARTNERS IV, INC | NEVADA | 0 | 0 | 0 | 0 | 0 | 0 % | 08/11/2024 |
| TANG CAPITAL PARTNERS III, INC | NEVADA | 0 | 0 | 0 | 0 | 0 | 0 % | 08/11/2024 |
| Roderick Wong, M.D. | 0 | 2298662 | 0 | 0 | 2298662 | 5.2 % | 14/02/2024 | |
| RTW Investments, LP | 0 | 2298662 | 0 | 0 | 2298662 | 5.2 % | 14/02/2024 | |
| Morgan Stanley | Delaware. | 0 | 4184978 | 0 | 13 | 4186578 | 9.5 % | 08/02/2024 |
| Morgan Stanley & Co. LLC | Delaware. | 0 | 4025351 | 0 | 13 | 4025351 | 9.1 % | 08/02/2024 |
| Avidity Capital Partners Fund (GP) LP | Delaware | 0 | 3750000 | 0 | 3750000 | 3750000 | 8.5 % | 27/10/2022 |
| Avidity Partners Management LP | Delaware | 0 | 3750000 | 0 | 3750000 | 3750000 | 8.5 % | 27/10/2022 |
| David Witzke | Delaware | 0 | 3750000 | 0 | 3750000 | 3750000 | 8.5 % | 27/10/2022 |
| Michael Gregory | Delaware | 0 | 3750000 | 0 | 3750000 | 3750000 | 8.5 % | 27/10/2022 |
| Avidity Partners Management (GP) LLC | Delaware | 0 | 3750000 | 0 | 3750000 | 3750000 | 8.5 % | 27/10/2022 |
| Avidity Master Fund LP | Delaware | 0 | 3053256 | 0 | 3053256 | 3053256 | 6.9 % | 27/10/2022 |
| Avidity Capital Partners (GP) LLC | Delaware | 0 | 3750000 | 0 | 3750000 | 3750000 | 8.5 % | 27/10/2022 |
| Biotechnology Value Trading Fund OS LP | Delaware | 0 | 0 | 0 | 357472 | 357472 | 1 % | 12/07/2022 |
| BVF Partners L.P. | Delaware | 0 | 0 | 0 | 8748629 | 8748629 | 19.9 % | 12/07/2022 |
| BVF Inc. | Delaware | 0 | 0 | 0 | 8748629 | 8748629 | 19.9 % | 12/07/2022 |
| Mark N. Lampert | Delaware | 0 | 0 | 0 | 8748629 | 8748629 | 19.9 % | 12/07/2022 |
| BVF GP Holdings LLC | Delaware | 0 | 0 | 0 | 8204369 | 8204369 | 18.6 % | 12/07/2022 |
| BVF Partners OS Ltd. | Delaware | 0 | 0 | 0 | 357472 | 357472 | 1 % | 12/07/2022 |
| Biotechnology Value Fund, L.P. | Delaware | 0 | 0 | 0 | 4712590 | 4712590 | 10.7 % | 12/07/2022 |
| BVF I GP LLC | Delaware | 0 | 0 | 0 | 4712590 | 4712590 | 10.7 % | 12/07/2022 |
| Biotechnology Value Fund II, L.P. | Delaware | 0 | 0 | 0 | 3491779 | 3491779 | 7.9 % | 12/07/2022 |
| BVF II GP LLC | Delaware | 0 | 0 | 0 | 3491779 | 3491779 | 7.9 % | 12/07/2022 |
| Robin C. John | United States | 0 | 3318647 | 0 | 0 | 3318647 | 7.5 % | 14/02/2022 |
| Eventide Asset Management, LLC | Delaware | 3318647 | 0 | 3318647 | 0 | 3318647 | 7.5 % | 14/02/2022 |
| Finny Kuruvilla, M.D. Ph. D. | United States | 0 | 3318647 | 0 | 0 | 3318647 | 7.5 % | 14/02/2022 |
| Roderick Wong | United States | 0 | 2637192 | 0 | 0 | 2637129 | 6 % | 14/02/2022 |
| RTW Investments, LP | Delaware | 0 | 2637192 | 0 | 0 | 2637192 | 6 % | 14/02/2022 |
| Vivo Opportunity, LLC | 624902 | 0 | 624902 | 0 | 624902 | 1.4 % | 11/02/2022 | |
| Vivo Capital IX, LLC | 119156 | 0 | 119156 | 0 | 119156 | 0.3 % | 11/02/2022 | |
| Pfizer Inc. 13-5315170 | Delaware | 1675000 | 0 | 1675000 | 0 | 1675000 | 3.81 % | 11/02/2022 |
| EIN #00-0000000 | Jersey, Channel Islands | 0 | 3404707 | 0 | 3404707 | 3404707 | 7.7 % | 11/02/2022 |
| Soleus Capital, LLC | 3525457 | 0 | 3525457 | 0 | 3525457 | 8.01 % | 10/02/2022 | |
| DRIEHAUS CAPITAL MANAGEMENT LLC | Delaware USA | 0 | 0 | 0 | 0 | 0 | 0 % | 23/08/2021 |
| RTW Investments, LP | Cayman Islands | 0 | 3028719 | 0 | 3028719 | 3028719 | 7.49 % | 02/07/2021 |
| Roderick Wong | Cayman Islands | 0 | 3028719 | 0 | 3028719 | 3028719 | 7.49 % | 02/07/2021 |
| RTW Master Fund, Ltd. | Cayman Islands | 0 | 2049713 | 0 | 2049713 | 2049713 | 5.07 % | 02/07/2021 |
| I.R.S. Identification Nos. of above persons (entities only): N/A | Curacao | 0 | 1985814 | 0 | 1985814 | 1985814 | 5.1 % | 05/05/2021 |
| DRIEHAUS CAPITAL MANAGEMENT LLC | Delaware USA | 0 | 1048524 | 0 | 1 | 1048524 | 5.03 % | 16/02/2021 |
| DRIEHAUS CAPITAL MANAGEMENT LLC | Delaware USA | 0 | 1048524 | 0 | 1 | 1048524 | 5.03 % | 16/02/2021 |
| Vivo Capital IX, LLC | Delaware | 314739 | 0 | 314739 | 0 | 314739 | 1 % | 06/11/2020 |
| Vivo Opportunity, LLC | Delaware | 1410514 | 0 | 1410514 | 0 | 1410514 | 4.4 % | 06/11/2020 |
| Pfizer Inc. | Delaware | 1675000 | 0 | 1675000 | 0 | 1675000 | 6 % | 06/08/2020 |
| OrbiMed Capital GP VI LLC | Delaware | 0 | 1471853 | 0 | 0 | 1471853 | 7.1 % | 12/11/2019 |
| OrbiMed Advisors LLC | Delaware | 0 | 1471853 | 0 | 0 | 1471853 | 7.1 % | 12/11/2019 |
| Eventide Asset Management, LLC | Delaware | 2010168 | 0 | 2010168 | 0 | 2010168 | 9.68 % | 30/08/2019 |
| Finny Kuruvilla, M.D. Ph.D. | United States | 0 | 2010168 | 0 | 0 | 2010168 | 9.68 % | 30/08/2019 |
| Soleus Capital, LLC | Delaware USA | 2138262 | 0 | 2138262 | 0 | 2138262 | 9.99 % | 29/08/2019 |
| Eventide Gilead Fund | Ohio | 0 | 618974 | 0 | 10 | 618974 | 8.6 % | 23/05/2019 |
| Finny Kuruvilla, M.D. Ph.D. | United States | 0 | 1385970 | 0 | 10 | 1385970 | 19.2 % | 23/05/2019 |
| Eventide Healthcare & Life Sciences Fund | Ohio | 0 | 766996 | 0 | 10 | 766996 | 10.6 % | 23/05/2019 |
| Eventide Asset Management, LLC | Delaware | 1385970 | 0 | 1385970 | 10 | 1385970 | 19.2 % | 23/05/2019 |
| Eventide Asset Management, LLC | Delaware | 2719410 | 0 | 2719410 | 0 | 2719410 | 9.3 % | 12/02/2018 |
| BVF Partners OS Ltd. | Delaware | 0 | 0 | 0 | 813606 | 813606 | 1 % | 16/01/2018 |
| Biotechnology Value Trading Fund OS LP | Delaware | 0 | 0 | 0 | 813606 | 813606 | 1 % | 16/01/2018 |
| BVF Inc. | Delaware | 0 | 0 | 0 | 10000000 | 10000000 | 9.9 % | 16/01/2018 |
| Mark N. Lampert | Delaware | 0 | 0 | 0 | 10000000 | 10000000 | 9.9 % | 16/01/2018 |
| Biotechnology Value Fund, L.P. | Delaware | 0 | 0 | 0 | 4734372 | 4734372 | 4.7 % | 16/01/2018 |
| Biotechnology Value Fund II, L.P. | Delaware | 0 | 0 | 0 | 3140828 | 3140828 | 3.1 % | 16/01/2018 |
| BVF Partners L.P. | Delaware | 0 | 0 | 0 | 10000000 | 10000000 | 9.9 % | 16/01/2018 |
| Eventide Asset Management, LLC | Delaware | 2719410 | 0 | 2719410 | 0 | 2719410 | 9.3 % | 13/02/2017 |
| William C. Newton, Gloria A. Newton | Delaware, United States | 1696968 | 0 | 1696968 | 0 | 1690000 | 12.46 % | 10/02/2017 |
| Richard M. Glickman | Canada | 812500 | 0 | 812500 | 0 | 812500 | 2.9 % | 25/01/2016 |
| 9.28% (2) | Cayman Islands | 0 | 2606059 | 0 | 2606059 | 2606059 | 9.28 % | 22/01/2016 |
| 9.28% (2) | Cayman Islands | 0 | 2606059 | 0 | 2606059 | 2606059 | 9.28 % | 22/01/2016 |
| 9.28% (2) | Cayman Islands | 0 | 2606059 | 0 | 2606059 | 2606059 | 9.28 % | 22/01/2016 |
| 9.28% (2) | Cayman Islands | 0 | 2606059 | 0 | 2606059 | 2606059 | 9.28 % | 22/01/2016 |
| 9.28% (2) | Cayman Islands | 0 | 2606059 | 0 | 2606059 | 2606059 | 9.28 % | 22/01/2016 |
| 9.28% (2) | Cayman Islands | 0 | 2606059 | 0 | 2606059 | 2606059 | 9.28 % | 22/01/2016 |
| Deerfield Management Company, L.P. | Delaware | 0 | 1859282 | 0 | 0 | 1859282 | 8.22 % | 20/07/2015 |
| James E. Flynn | Delaware | 0 | 1859282 | 0 | 0 | 1859282 | 8.22 % | 20/07/2015 |
| Deerfield Mgmt, L.P. | Delaware | 0 | 950191 | 0 | 0 | 950191 | 4.2 % | 20/07/2015 |
| Deerfield Mgmt III, L.P. | Delaware | 0 | 909091 | 0 | 0 | 909091 | 4.02 % | 20/07/2015 |
| Deerfield Private Design Fund III, L.P. | Delaware | 0 | 909091 | 0 | 0 | 909091 | 4.02 % | 20/07/2015 |
| Deerfield Special Situations Fund, L.P. | Delaware | 0 | 950191 | 0 | 0 | 950191 | 4.2 % | 20/07/2015 |